← Advocacy

The Welsh Gender Service pause: where the record stands

ADVOCACY · 6 October 2026

Welsh Gender Service — our coverage

  1. Our position — what was decided, what has not been shown, and what we ask
  2. What the published record shows — the running record, updated as the position changes, with full revision history
  3. The papers justifying the gender surgery pause do not hold up — the two impact assessments published on 17 September
  4. What the Joint Committee said, and what it did not — the meeting of 22 September, with a timestamp index to the recording
  5. The pause may be right. The process cannot show it — where this stands, stated as a view
  6. The terms of reference, read in full — the governing document of the review
  7. The published record, analysed — nineteen documents read against each other (seventeen at publication, two added since), every finding graded and independently checked
  8. Where the record stands — our view after the terms of reference, and eight things we ask (you are here)
  9. Our correspondence — every approach to a public body, what was asked, and where each stands
  10. Commitments made — what these bodies have promised, and whether it has been kept

NHS WALES · WELSH GENDER SERVICE · OPINION

This is an opinion piece. Its factual claims rest on the published record. Most are cited to our analysis of it by section number, as “Analysis §n”; the rest are cited to the primary document. Where we give a view, we say so. Published 6 October 2026 (UK time).

Our position

The pause may be justified. The published record does not show that it is.

In our view, the terms of reference for the independent review are the most careful document the NHS Wales Joint Commissioning Committee has published on this matter. They refuse to treat a high referral rate as proof of inappropriate referral, and they separate what was reasonable at the time from what is right now. We welcome that.

But the parts of the review that decide what happens to patients have not been published. People waiting to be referred are in no stage of the review, though it is the review that is to establish whether referrals can resume. In our view the published evidence for pausing all three procedures, for new and existing patients alike, is thin and inconsistent. And the record of the decision is not yet public. The Committee dates it to 24 August. A Joint Committee lay member has said it was scrutinised in a private session of the quality sub-committee, and the Committee Secretary has said those minutes will be published.

Our view is that the Committee should publish what is missing, close the gaps listed below, and publish a procedure-by-procedure review of whether a pause this wide remains proportionate. None of that requires anyone to accept or reject the concerns behind the pause. It only requires the process to be visible.

What the record supports

Some of the Committee’s case stands on its own figures, and we say so plainly.

A higher referral rate is a reasonable signal to investigate. The terms of reference treat it, together with the progression figure, clinical advisers’ concerns and complaints, as “a reasonable basis for further independent review” (terms of reference), and we agree.

What the record does not support

The published record does not show that referrals were inappropriate, that a pause of this width was needed, or how the review will decide anyone’s case.

Is the pause proportionate?

In our view, the published record does not show that a pause of this width is proportionate. It does not show that it is disproportionate either. The Chief Commissioner has said a narrower and a wider option were considered, and that clinicians advised the decision taken, but that advice is not published. The Committee holds information the public does not, which is exactly why it should publish enough to let others judge.

Our reasons:

  1. The pause is wider than the procedure-specific evidence. The documents give a combined rationale: referral rates higher for all three procedures, lower progression to masculinising genital surgery, clinical advisers’ concerns and complaints. The terms of reference say the rate difference “does not, in isolation, establish that either the Welsh or English referral threshold is clinically appropriate”. Neither the advisers’ concerns nor the complaints are published by procedure. That leaves the progression figure as the only published evidence pointing to a problem with one procedure, rather than a difference in rates. Yet the pause covers new referrals, assessments and surgery for all three. The terms of reference allow referrals or surgery to resume “for defined groups of patients”, but no document says which groups might qualify or when (terms of reference; Analysis §3).
  2. The Committee’s own papers set the test. The Quality Impact Assessment says the pause “carries material negative impacts for affected patients, including delay, distress, uncertainty and potential loss of trust”, names “mental health risk”, and says proportionality “should be kept under regular review”. The equality assessment commits to reviewing the pause regularly “to ensure it remains necessary, objectively justified, proportionate and time-limited”. No such review has been published. In our view, the interim review after 30 cases is one point at which it could be done (Quality Impact Assessment; equality assessment action plan; Analysis §6, §7.2).
  3. The delay falls hardest on those nearest surgery. About 450 to 500 people are potentially affected. The Quality Impact Assessment argues the effect on overall pathway efficiency is “limited”, because some waits are already up to about eight years and patients who are reassessed and found clinically appropriate return “in their original chronological position”. It also recognises that this “does not remove the potential impact on individual patients, particularly those who were closer to a planned surgical date”, which it says will be mitigated by prioritising them in the review. For them, every month of pause is still added delay (Quality Impact Assessment; Analysis §3.2, §3.3, §6).
  4. No end point has been set. The FAQs say “it is not possible to confirm when referrals may resume”. One answer ties restarting referrals to “any identified improvements” being addressed; the terms of reference instead separate actions needed before restart from longer-term improvements (FAQs; Analysis §7.2).

The Committee may be right to pause. If it is, publishing the basis, in a form that protects patients’ confidentiality, would cost it little and would answer most of what we raise.

What we ask

We ask the NHS Wales Joint Commissioning Committee to do these eight things. Each answers a specific gap in the record.

# We ask the Committee to Because Analysis
1 Publish the review framework, the “defined governance process” and the interim-review criteria before they are used on any patient They decide who is reinstated, deferred or removed, and none is public §4.3
2 Say how people waiting to be referred will be assessed, and when They are in no stage of the review, yet the review is to establish whether referrals can resume §4.5
3 Confirm that a flag on smoking or BMI alone will not lead to deferral or removal NHS England specification 1780, the one that fits the terms of reference’s description, says referral “may still be made” in both cases §5.2
4 Commit to reviewing all of the roughly 60 people whose surgery was due by 31 December, or say what happens to those not reviewed The terms of reference make the second 30 conditional; patients have been told their records “will be reviewed” §4.4
5 Publish the patient numbers behind the progression rates, and progression for feminising surgery The numbers were promised in September; a feminising-surgery rate would show whether the concern is specific to one procedure §3.2
6 Publish the decision record: the minutes of the sub-committee’s private session, the paper before it, and the meeting that took the decision The Committee Secretary has said the minutes and the paper will be published; the public papers of 24 August do not record the decision §2
7 Write into the review the commitments in the papers put to the Joint Committee: an equality assessment at the outset, protection of waiting-list position, and a role for patient groups and Llais They appear in the impact assessments, or were given orally, but not in the terms of reference (updated 12 October 2026: Llais tells us it was invited to comment on the terms of reference before they were finalised, and was told people’s experiences will be considered as part of the wider service review; neither is a role in this review written into its terms) §6
8 Publish a dated, procedure-by-procedure review of whether the pause remains proportionate Both impact assessments call for the pause’s proportionality to be kept under review, and no review has been published (QIA; EWLIA) §6

We also ask Cardiff and Vale University Health Board to bring its FAQs into line with the terms of reference: on the consultation with NWJCC and surgical providers before decisions are taken, on when the pause ends, and on what the desk review can lead to (Analysis §7.2).

What would change our view

We would revise this view, and say so publicly, if any of the following were published.

If the evidence shows the pause was needed, we will say so.

What we are not saying

Our interests. Eden Openly is a party to this matter, not a neutral observer. We have written to the Committee (copying Cardiff and Vale University Health Board on our first letter), to Cardiff and Vale directly on 6 October (added 10 October 2026; this line previously omitted that letter), to Cwm Taf Morgannwg University Health Board, which handles information requests on its behalf, and to Llais, and we have made submissions to two Senedd committees. Our correspondence is published at edenopenly.com/wgs-correspondence. We hold no privileged information. Everything here rests on documents anyone can read.

Sources

This piece rests on our analysis of the published record, which grades each finding and gives every quotation with its source: The Welsh Gender Service pause: an analysis of the published record. Its section numbers are cited above as “Analysis §n”.

The primary documents:

Eden Openly is an independent clinical health-education publication. It receives no funding from, and has no commercial relationship with, any provider of gender-related healthcare, any pharmaceutical company, or any supplier of NHS digital systems. Our full position is in our statement of independence. Corrections and queries: [email protected].

More Advocacy

View all →
What we told the UN about hormone therapy in detention
Advocacy Read essay →
Done carefully enough it is not a crime
Advocacy Read essay →
The Welsh Gender Service pause- an analysis of the published record
Advocacy Read essay →